Title: Self Administration of MTP Pills and Risk of Ectopic Pregnancy

Authors: Dr Meenakshi Rana, Dr Neha Singh

 DOI: https://dx.doi.org/10.18535/jmscr/v9i12.25

Abstract

Objective: The objective was to study the risk of the ectopic pregnancy in patients with self administration of the MTP Pills reporting to a tertiary care centre with different complaint

Methodology: This study was conducted in the department of Obstetrics and Gynecology, Kamla Nehru State hospital, Indira Gandhi medical college Shimla w.e.f. 1st July 2018 to 30th June 2019. It was a prospective observational study. A total of 25 women reported to our hospital after self administration of abortion pills were diagnosed of having ectopic pregnancy.

Observations and Results: In this study a total of 25 cases presented to the hospital with different complaints who were diagnosed to have ectopic pregnancy. maximum patients (72%)were in age group of 21-30 years.77% were married. 52% belonged to rural area. 60% patients had ruptured ectopic and 32% had unruptured ectopic.

Conclusion: This study shows that there is a high risk of ectopic pregnancy associated with self administred MTP Pills and due to the easy availability of abortion drugs there ia an urgent requirement of legislation and restriction of drugs used for medical termination of pregnancy. In patients with self administered MTP pills ectopic pregnancy may remain under-diagnosed hitch may lead to potentially serious consequences.

References

  1. Cunningham FG, Leveno KJ, Bloom SL, Haulh JC, Gilstrap LC, Wenstrom KD, editors. Abortion. Williams Textbook of Obstetrics, 24th ed. New York: McGraw-Hill; 2014. pp. 215–235.
  2. Mittal S. Guidelines for medical abortion in India. In: Consortium on national consensus for medical abortion in India: WHO–CCR in human reproduction. All India Institute of Medical Sciences, New Delhi.
  3. Tran NT, Jang MC, Choe YS, et al. Feasibility, effificacy, safety, and acceptability of mifepristone misoprostol for medical abortion in the Democratic People’s Republic of Korea. Int J Gynaecol Obstet.2010;109(3):209–12.
  4. Mifepristone can be sold only to approved MTP Centres: Rajasthan State HRC. Indian Express Health Care Management. May 2004.
  5. Fielding SL, Schaff EA, Nam NY. Clinicians’ perception of sonogram indication for mifepristone abortion up to 63 days. Contraception. 2002;66:27–31.
  6. International Consensus Conference on Non-surgical (Medical) Abortion in Early First Trimester on Issues Related to Regimens and Service Delivery. Frequently asked clinical questions about medical abortion. Geneva: World Health Organization; 2006. ISBN 92-4-159484-5.
  7. Thaker RV, Deliwala KJ, Shah PT. Self medication of abortion pill: women’s Health in Jeopardy. NHL J Med Sci. 2014; 3(1):26–31.
  8. Iyenger S. Current status of abortion in India. In: Consortium on national consensus for medical abortion in India: WHO–CCR in human reproduction. All India Institute of Medical Sciences, New Delhi.
  9. Joshi AP, Chitrakar NS, Pariyar J, Shrestha I, Maharjan R, Maharjan P. Undiagnosed Ectopic Pregnancy among Unsupervised use of Medical Abortion pills. Nepal JO bstet Gynecol 2016; 22(2):12-15.
  10. Debnath J, Gulati SK, Mathur A, Gupta R, Kumar N, Arora S. Ectopic pregnancy in the Era of Medical Abortion: Are We Ready for it? Spectrum of Sonographic Findings and Our Experience in a Tertiary Care Service Hospital of India. J Obstet Gynecol India 2013;63(6):388-93.

Corresponding Author

Dr Neha Singh

Junior Resident Department of Obstetrics and Gynaecology, IGMC Shimla